Is GPR119 agonism an appropriate treatment modality for the safe amelioration of metabolic diseases?

Full text for this resource is not available from the Research Repository.

Cornall, Lauren, Mathai, Michael ORCID: 0000-0001-8783-2122, Hryciw, Deanne H ORCID: 0000-0003-1697-8890 and McAinch, Andrew ORCID: 0000-0002-8762-4865 (2013) Is GPR119 agonism an appropriate treatment modality for the safe amelioration of metabolic diseases? Expert Opinion on Investigational Drugs, 22 (4). pp. 487-498. ISSN 1354-3784 (print) 1744-7658 (online)

Dimensions Badge

Altmetric Badge

Item type Article
URI https://vuir.vu.edu.au/id/eprint/21973
DOI 10.1517/13543784.2013.775245
Subjects Historical > Faculty/School/Research Centre/Department > School of Biomedical and Health Sciences
Historical > FOR Classification > 1101 Medical Biochemistry and Metabolomics
Historical > FOR Classification > 1103 Clinical Sciences
Keywords GPR119, insulin, type 2 diabetes mellitus, metabolic disease, drug therapy, skeletal muscle, metabolism
Citations in Scopus 19 - View on Scopus
Download/View statistics View download statistics for this item

Search Google Scholar

Repository staff login